Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110868

Lipoxygenase Pathway in Islet Endocrine Cells. OXIDATIVE METABOLISM OF ARACHIDONIC ACID PROMOTES INSULIN RELEASE

Stewart Metz, Michael VanRollins, Robert Strife, Wilfred Fujimoto, and R. Paul Robertson

Division of Clinical Pharmacology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Pharmacology, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

University of Washington, Seattle, Washington 98195

Find articles by Metz, S. in: PubMed | Google Scholar

Division of Clinical Pharmacology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Pharmacology, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

University of Washington, Seattle, Washington 98195

Find articles by VanRollins, M. in: PubMed | Google Scholar

Division of Clinical Pharmacology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Pharmacology, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

University of Washington, Seattle, Washington 98195

Find articles by Strife, R. in: PubMed | Google Scholar

Division of Clinical Pharmacology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Pharmacology, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

University of Washington, Seattle, Washington 98195

Find articles by Fujimoto, W. in: PubMed | Google Scholar

Division of Clinical Pharmacology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Pharmacology, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Division of Clinical Endocrinology and Metabolism, Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

University of Washington, Seattle, Washington 98195

Find articles by Robertson, R. in: PubMed | Google Scholar

Published May 1, 1983 - More info

Published in Volume 71, Issue 5 on May 1, 1983
J Clin Invest. 1983;71(5):1191–1205. https://doi.org/10.1172/JCI110868.
© 1983 The American Society for Clinical Investigation
Published May 1, 1983 - Version history
View PDF
Abstract

Metabolism of arachidonic acid (AA) via the cyclooxygenase pathway reduces glucose-stimulated insulin release. However, metabolism of AA by the lipoxygenase pathway and the consequent effects on insulin secretion have not been simultaneously assessed in the endocrine islet. Both dispersed endocrine cell-enriched pancreatic cells of the neonatal rat, as well as intact islets of the adult rat, metabolized [3H]AA not only to cyclooxygenase products (prostaglandins E2, F2α, and prostacyclin) but also to the lipoxygenase product 12-hydroxyeicosatetraenoic acid (12-HETE). 12-HETE was identified by coelution with authentic tritiated or unlabeled 12-HETE using four high performance liquid chromatographic systems under eight mobile-phase conditions and its identity was confirmed by gas chromatography/mass spectrometry using selected ion monitoring. The predominant effect of exogenous AA (5 μg/ml) was to stimulate insulin release from pancreatic cells grown in monolayer. This effect was concentration- and time-dependent, and reversible. The effect of AA upon insulin release was potentiated by a cyclooxygenase inhibitor (indomethacin) and was prevented by either of two lipoxygenase inhibitors (5,8,11,14-eicosatetraynoic acid [ETYA] and BW755c). In addition, glucose, as well as two structurally dissimilar agents (the calcium ionophore A23187 and bradykinin), which activate phospholipase(s) and thereby release endogenous AA in several cell systems, also stimulated insulin secretion. The effects of glucose, glucagon, bradykinin and high concentrations of A23187 (5 μg/ml) to augment insulin release were blocked or considerably reduced by lipoxygenase inhibitors. However, a lower concentration of the ionophore (0.25 μg/ml), which did not appear to activate phospholipase, was resistant to blockade. Exogenous 12-HETE (up to 2,000 ng/ml) did not alter glucose-induced insulin release. However, the labile intermediate 12-hydroperoxy-ETE increased insulin release. Furthermore, diethylmaleate (which binds intracellular glutathione and thereby impedes conversion of the lipoxygenase intermediates hydroperoxy-ETE and leukotriene A4 to HETE and leukotriene C4, respectively) potentiated the effect of glucose and of exogenous AA. Finally, 5,6-epoxy, 8,11,14-eicosatrienoic acid (a relatively stable epoxide analogue of leukotriene A4) as well as two other epoxy-analogues, potentiated glucose-induced insulin release. We conclude that dual pathways of AA metabolism exist in islet endocrine cells and have opposing regulatory effects on the beta cell—an inhibitory cyclooxygenase cascade and a stimulatory lipoxygenase cascade. Labile products of the latter pathway may play a pivotal role in stimulus-secretion coupling in the islet.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1191
page 1191
icon of scanned page 1192
page 1192
icon of scanned page 1193
page 1193
icon of scanned page 1194
page 1194
icon of scanned page 1195
page 1195
icon of scanned page 1196
page 1196
icon of scanned page 1197
page 1197
icon of scanned page 1198
page 1198
icon of scanned page 1199
page 1199
icon of scanned page 1200
page 1200
icon of scanned page 1201
page 1201
icon of scanned page 1202
page 1202
icon of scanned page 1203
page 1203
icon of scanned page 1204
page 1204
icon of scanned page 1205
page 1205
Version history
  • Version 1 (May 1, 1983): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts